CLINICAL_TRIALS
research
· 2025-10-08
Clinical Trial Update: Stereotactic Body Radiation Therapy Planning With Artificial Intelligence-Directed Dose Recommendation for Treatment of Primary or Metastatic Lung Tumors, RAD-AI Study [NA]
Summary
The RAD-AI study seeks to use artificial intelligence-directed dose planning for stereotactic body radiation therapy in patients with primary or metastatic lung…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Northwestern University | Conditions: Lung Carcinoma, Lung Non-Small Cell Carcinoma | NA | Status: RECRUITING